Fig. 6.
Fig. 6. (A) Stimulation with anti-CD95 (anti-Fas) MoAb (0.1 to 2 μg/mL) for 19 hours resulted in a significant reduction of respiratory burst in unstimulated (▪) and fMLP (10−7mol/L) activated (•) eosinophils as determined by lucigenin-dependent chemiluminescence. (B) Stimulation with 10 to 100 μmol/L SA (⧫) for 10 minutes significantly blocked fMLP (10−7mol/L)-induced eosinophil respiratory burst, whereas 500 μmol/L resulted in a significant enhancement (not shown). Data are presented as mean ± SEM intensity counts of 8 different experiments. *P< .05, **P < .01.

(A) Stimulation with anti-CD95 (anti-Fas) MoAb (0.1 to 2 μg/mL) for 19 hours resulted in a significant reduction of respiratory burst in unstimulated (▪) and fMLP (10−7mol/L) activated (•) eosinophils as determined by lucigenin-dependent chemiluminescence. (B) Stimulation with 10 to 100 μmol/L SA (⧫) for 10 minutes significantly blocked fMLP (10−7mol/L)-induced eosinophil respiratory burst, whereas 500 μmol/L resulted in a significant enhancement (not shown). Data are presented as mean ± SEM intensity counts of 8 different experiments. *P< .05, **P < .01.

Close Modal

or Create an Account

Close Modal
Close Modal